Cancer Vaccines
Major Milestone for Melbourne-Based Drug Development Company the Latest Testament to Strength and Success of Australia's Leading Biotechnology Sector
Published in Vaccine Weekly, December 15th, 2010
2010 DEC 15 -- The State Government of Victoria, Australia announced the continued success of its thriving biotechnology industry, as evidenced by the recent news from Melbourne-based drug delivery company Acrux. The company announced that the United States Food and Drug Administration (FDA) approved its Axiron® topical solution CIII for testosterone replacement therapy in men. Axiron is the first testosterone topical solution approved for application via an underarm applicator.
This major milestone is just the latest testament to the strength of Victoria's biotech sector. The state has long been a hotbed for biotech innovation down under. Home to life...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2010-12-15)
More Articles from Vaccine Weekly
- Pediatric Vaccines
Preterm infants may need a boost - Active Immunotherapy
Reports from Marmara University, Faculty of Medicine advance knowledge in active immunotherapy - Hepatitis
Reports from University of Cincinnati, Department of Pediatrics highlight recent research in hepatitis - Pediatric Vaccines
Research from Aga Khan University in the area of pediatric vaccines published - Pediatric Vaccines
Research from University of Santiago in pediatric vaccines provides new insights - Pediatric Vaccines
Study data from S.J. Moss et al provide new insights into pediatric vaccines - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
